279 related articles for article (PubMed ID: 31998788)
21. Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma.
Ohe C; Kuroda N; Takasu K; Senzaki H; Shikata N; Yamaguchi T; Miyasaka C; Nakano Y; Sakaida N; Uemura Y
Med Mol Morphol; 2012 Jun; 45(2):98-104. PubMed ID: 22718295
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid CB1 receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Larrinaga G; Sanz B; Blanco L; Perez I; Candenas ML; Pinto FM; Irazusta A; Gil J; López JI
Clin Biochem; 2013 May; 46(7-8):638-41. PubMed ID: 23318578
[TBL] [Abstract][Full Text] [Related]
23. Identification of
Wang S; Yu ZH; Chai KQ
Oncol Lett; 2019 Aug; 18(2):1767-1774. PubMed ID: 31423244
[TBL] [Abstract][Full Text] [Related]
24. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
Ge YZ; Xin H; Lu TZ; Xu Z; Yu P; Zhao YC; Li MH; Zhao Y; Zhong B; Xu X; Zhou LH; Wu R; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
Sci Rep; 2015 May; 5():10328. PubMed ID: 25981392
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
27. ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.
Qiu X; Gu Y; Ni Y; Li Q
Biomed Res Int; 2020; 2020():2064582. PubMed ID: 33178820
[TBL] [Abstract][Full Text] [Related]
28. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Tong K; Hu Z
Virchows Arch; 2021 Apr; 478(4):647-658. PubMed ID: 32812119
[TBL] [Abstract][Full Text] [Related]
29. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
30. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
[TBL] [Abstract][Full Text] [Related]
31. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
[TBL] [Abstract][Full Text] [Related]
32. FOXI1 Immunohistochemistry Differentiates Benign Renal Oncocytoma from Malignant Chromophobe Renal Cell Carcinoma.
Molnar A; Horvath CA; Czovek P; Szanto A; Kovacs G
Anticancer Res; 2019 Jun; 39(6):2785-2790. PubMed ID: 31177114
[TBL] [Abstract][Full Text] [Related]
33. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
[TBL] [Abstract][Full Text] [Related]
34. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
35. Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma.
Kowalewski A; Szylberg Ł; Tyloch J; Antosik P; Neska-Długosz I; Frąckowski Ł; Tyloch D; Purpurowicz P; Grzanka D
Pathol Oncol Res; 2019 Oct; 25(4):1519-1524. PubMed ID: 30467700
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
Wu J; Zhu Q; Zhu W; Chen W; Wang S
Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic and Genomic Factors Associated With Oncologic Outcome in Patients With Stage III to IV Chromophobe Renal Cell Carcinoma.
Beksac AT; Bicak M; Paranjpe I; Paulucci DJ; Sfakianos JP; Badani KK
Clin Genitourin Cancer; 2019 Apr; 17(2):e314-e322. PubMed ID: 30639042
[TBL] [Abstract][Full Text] [Related]
38. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
Wang Y; Wang Y; Liu F
Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
[TBL] [Abstract][Full Text] [Related]
39. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Zeng Q; Zhang W; Li X; Lai J; Li Z
Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
